← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2004First marketed drug
Aug 30, 1996First NDA
Aug 30, 1996Last known activity
May 28, 2021
Acquired by Covis → Advanz Pharma on Nov 16, 2020
Timeline
1980s
- Jul 1, 1981
AMAG Pharmaceuticals, Inc.— Founded
1990s
- Aug 30, 1996
ferumoxides— NDA Secondary Org
- Aug 30, 1996
ferumoxides— NDA Organization
2010s
- Jan 1, 2014
Lumara Health— Acquired
- Jan 1, 2015
Advanz Pharma— Now
- Jan 1, 2015
Cord Blood Registry, Inc.— Acquired
- Sep 26, 2018
Velo Bio, LLC— Acquired
- Dec 13, 2018
Perosphere, Inc.— Acquired
- Jun 21, 2019
bremelanotide— Marketing Organization
2020s
- Nov 16, 2020
Covis— Acquired By
Drugs by trial phase (34 distinct, 61 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (6 own, 4 via acquisition)
Phase 2 (7 own, 7 via acquisition)
Phase 1 (2 own, 2 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Anemia
- Anemia, Iron-Deficiency
- Aneurysm
- Atherosclerosis
- Atrophy
- Brain Neoplasms
- Breast Neoplasms
- Cardiovascular Diseases
- Communicable Diseases
- Deficiency Diseases
- Disease
- Esophageal Neoplasms
- Hemorrhage
- Hypokinesia
- Infections
- Intracranial Aneurysm
- Intracranial Arteriosclerosis
- Kidney Diseases
- Menorrhagia
- Nausea
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Premature Birth
- Psychomotor Agitation
- Renal Insufficiency, Chronic
- Restless Legs Syndrome
- Sexual Dysfunctions, Psychological
- Syndrome
- Urinary Tract Infections
- Uterine Hemorrhage
Marketed drugs (6)
Subsidiaries (4 direct, 4 total across the full acquisition tree)
Recent trials (44)
- NCT04908982CollaboratorPhase 4May 28, 2021
- NCT04493333CollaboratorPhase 2Dec 31, 2020
- NCT04593784Lead sponsorPhase 2Nov 1, 2020
- NCT04268849CollaboratorPhase 3Feb 17, 2020
- NCT04205266CollaboratorPhase 4Jan 31, 2020
- NCT04179734CollaboratorPhase 4Oct 7, 2019
- NCT03777514CollaboratorN/AAug 31, 2019
- NCT03740945CollaboratorPhase 3Jul 31, 2019
- NCT03973047Lead sponsorPhase 1Jun 30, 2019
- NCT03893045Lead sponsorPhase 3Jun 30, 2019
- NCT03854396CollaboratorPhase 3Jun 30, 2019
- NCT03619005CollaboratorPhase 3Sep 30, 2018
- NCT03657433CollaboratorPhase 3Sep 1, 2018
- NCT03619850Lead sponsorPhase 3Aug 13, 2018
- NCT03297216CollaboratorPhase 3Feb 7, 2018
Details
- Founded
- Lexington, MA, US Jul 1, 1981
- First NDA
- Aug 30, 1996
- Last known activity
- May 28, 2021